chr1-81943736-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001366006.2(ADGRL2):c.1177T>C(p.Ser393Pro) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 32)
Consequence
ADGRL2
NM_001366006.2 missense
NM_001366006.2 missense
Scores
9
9
Clinical Significance
Conservation
PhyloP100: 6.05
Genes affected
ADGRL2 (HGNC:18582): (adhesion G protein-coupled receptor L2) This gene encodes a member of the latrophilin subfamily of G-protein coupled receptors. The encoded protein participates in the regulation of exocytosis. The proprotein is thought to be further cleaved within a cysteine-rich G-protein-coupled receptor proteolysis site into two chains that are non-covalently bound at the cell membrane. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADGRL2 | NM_001366006.2 | c.1177T>C | p.Ser393Pro | missense_variant | 6/24 | ENST00000686636.1 | NP_001352935.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRL2 | ENST00000686636.1 | c.1177T>C | p.Ser393Pro | missense_variant | 6/24 | NM_001366006.2 | ENSP00000509478.1 | |||
ADGRL2 | ENST00000370725.5 | c.1165T>C | p.Ser389Pro | missense_variant | 8/26 | 5 | ENSP00000359760.1 | |||
ADGRL2 | ENST00000370723.5 | c.1165T>C | p.Ser389Pro | missense_variant | 8/25 | 5 | ENSP00000359758.1 | |||
ADGRL2 | ENST00000370728.5 | c.1165T>C | p.Ser389Pro | missense_variant | 8/25 | 5 | ENSP00000359763.1 | |||
ADGRL2 | ENST00000370727.5 | c.1165T>C | p.Ser389Pro | missense_variant | 8/25 | 5 | ENSP00000359762.1 | |||
ADGRL2 | ENST00000370730.5 | c.1165T>C | p.Ser389Pro | missense_variant | 8/24 | 5 | ENSP00000359765.1 | |||
ADGRL2 | ENST00000370721.5 | c.1177T>C | p.Ser393Pro | missense_variant | 9/25 | 5 | ENSP00000359756.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Cov.: 32
GnomAD4 exome
Cov.:
32
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 15, 2021 | The c.1165T>C (p.S389P) alteration is located in exon 5 (coding exon 4) of the ADGRL2 gene. This alteration results from a T to C substitution at nucleotide position 1165, causing the serine (S) at amino acid position 389 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Uncertain
D
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;T;.;.;D;.;.;.;.;.;T;D
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;.;D;D;.;D;.;D;D;D;D;D
M_CAP
Benign
D
MetaRNN
Uncertain
T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Benign
N;N;N;N;N;N;N;N;N;N;.;N
REVEL
Uncertain
Sift
Benign
T;T;T;T;T;T;T;T;T;T;.;T
Sift4G
Benign
T;T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.0030, 0.0050
.;.;.;.;.;.;B;B;B;B;.;.
Vest4
MutPred
0.53
.;Gain of catalytic residue at S389 (P = 0.0668);Gain of catalytic residue at S389 (P = 0.0668);Gain of catalytic residue at S389 (P = 0.0668);Gain of catalytic residue at S389 (P = 0.0668);Gain of catalytic residue at S389 (P = 0.0668);Gain of catalytic residue at S389 (P = 0.0668);Gain of catalytic residue at S389 (P = 0.0668);Gain of catalytic residue at S389 (P = 0.0668);Gain of catalytic residue at S389 (P = 0.0668);Gain of catalytic residue at S389 (P = 0.0668);Gain of catalytic residue at S389 (P = 0.0668);
MVP
MPC
0.92
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.